About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - GENETIC SIGNATURES LIMITED
GENETIC SIGNATURES LIMITED
Health Care
Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.
Read moreMarket Cap
281.39m
Price at Close
$1.97
4w avg. Volume
135.31k
4w avg. Turnover
$257.46k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| - | 27 Oct 2020 |
| - | 26 Oct 2020 |
| -2.91% | 22 Oct 2020 |
| +4.76% | 21 Oct 2020 |
| -1.03% | 16 Oct 2020 |
| -1.03% | 16 Oct 2020 |
| -1.03% | 16 Oct 2020 |
| +11.76% | 01 Oct 2020 |
| -2.50% | 10 Sep 2020 |
| -0.87% | 27 Aug 2020 |
Market Data
Current Price
$1.97
52WK HIGH
$2.94
52WK LOW
$0.9
1YR RETURN
+91.26%
1YR RETURN VS. SECTOR
-191.31%
90 DAY RETURN
-25.10%
ASX RANK
481
/2,015
SECTOR RANK
1
/9
SHARES OUTSTANDING
142.84m
GENETIC SIGNATURES LIMITED
Health Care
Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.
Read moreMarket Cap
281.39m
Price at Close
$1.97
4w avg. Volume
135.31k
4w avg. Turnover
$257.46k
ASX:GSS is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia